Efficacy of combination chemotherapy for stage IV colon cancer with extensive peritoneal dissemination and multiple liver metastases: A case report

Oncology Reports

Volumn 9, Issue 6, 2002, Pages 1339-1343

  Mukai, Masaya ^a   Oida, Yasuhisa ^a   Mukoyama, Sayuri ^a   Okamoto, Yuuichi ^a   Ito, Isao ^a   Nakasaki, Hisao ^a   Kawai, Kenji ^a   Sato, Shinkichi ^a   Makuuchi, Hiroyasu ^b  

^a TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Combination chemotherapy; Liver metastasis; Peritoneal dissemination

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; FLUOROURACIL; FOLINIC ACID;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; CASE REPORT; COLON RESECTION; COLON TUMOR; ECHOGRAPHY; FATALITY; HUMAN; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PERITONEUM TUMOR; PLEURA EFFUSION;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLECTOMY; COLONIC NEOPLASMS; FATAL OUTCOME; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PLEURAL EFFUSION;

EID: 0036834650     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.6.1339     Document Type: Article

References (20)

1. Mukai M, Noto T, Yasuda S, Tokuda Y, Hanaue H, Tajima T, Mitomi T, Tsutsumi Y and Osamura Y: An autopsy case of anticancer drug-induced gastroenterocolitis following effective chemotherapy. J Jpn Soc Cancer Ther (in Japanese with English abstract) 28: 942-948, 1993. (Pubitemid 23253197)
2. Mukai M, Tokunaga N, Yasuda S, Mukohyama S, Kameya T, Ishikawa K, Iwase H, Suzuki T, Ishida H, Sadahiro S and Hiroyasu M: Long-term survival after immunochemotherapy for juvenile colon cancer with peritoneal dissemination: a case report. Oncol Rep 7: 1343-1347, 2000.
3. Mukai M, Moriya H, Himeno S, Oida Y, Mukohyama S, Nishi T, Nakasaki H, Satoh S and Makuuchi H: Efficacy of oral UFT plus leucovorin therapy for colon cancer with ovarian and multiple liver metastases: report of two cases. Oncol Rep 8: 1079-1083, 2001. (Pubitemid 33758173)
4. Machover D, Schwarzenberg L, Goldschmidt E, Tourani JM, Michalski B, Hayat M, Dorval T, Misset JL, Jasmin C, Maral R and Mathé G: Treatment of advanced colorectal and gastric adenocarcinoma with 5-FU combined with high-dose folinic acid: a pilot study. Cancer Treat Rep 66: 1803-1807, 1982. (Pubitemid 12005299)
5. Petrelli N, Douglass HO Jr, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD, Muggia FM, Megibow A, Greenwald ES, Bukowski RM, Harris J, Levin B, Gaynor E, Loutfi A, Kalser MH, Barkin JS, Benedetto P, Woolley PV, Nauta R, Weaver DW, Leichman LP for the Gastrointestinal Tumor Study Group: The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 7: 1419-1426, 1989. (Pubitemid 19245111)
6. O'Connell MJ: A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. Cancer 63: 1026-1030, 1989.
7. De Gramont A, Bosset J-F, Milan C, Rougier P, Bouché O, Etienne P-L, Morvan F, Louvet C, Guillot T, François E and Bedenne L: Randomized trial comparing monthly low dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer. J Clin Oncol 15: 808-815, 1997. (Pubitemid 27074252)
8. Maindrault-Goebel F, Louvet C, André T, Carola E, Lotz JP, Molitor JL, Garcia ML, Gilles-Amar V, Izrael V, Krulik M and de Gramont A, on behalf of GERCOR: Oxaliplatin added to the simplified bimonthly leucovorin 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). Eur J Cancer 35: 1338-1342, 1999. (Pubitemid 29397433)
9. Giacchetti S, Perpoint B, Zidani R, Bail NL, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y, Coudert B, Bertheaut-Cvitkovic F, Larregain-Fournier D, Rol AL, Walter S, Adam R, Misset JL and Lévi F: Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18: 136-147, 2000. (Pubitemid 30036347)
10. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Bail NL, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F and Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938-2947, 2000. (Pubitemid 30644117)
11. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL and Miller LL, for the Irinotecan Study Group: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343: 905-914, 2000.
12. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandic P, Iveson T, Carmichael J, Alaki M, Gruia G, Awad L and Rougier P: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 355: 1041-1047, 2000. (Pubitemid 30162806)
13. Itoh K, Yamashita T, Wakita H, Watanabe Y, Kodama K, Fujii H, Minami H, Ohtsu T, Igarashi T and Sasaki T: Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases. Jpn J Clin Oncol 28: 343-346, 1998. (Pubitemid 128522961)
14. 14 by liver, intestinal mucosa, and Flexner-jobling carcinoma in the rat. Cancer Res 17: 399-404, 1957.
15. Duschinsky R, Pleven E and Heidelberger C: The synthesis of 5-fluoropyrimidines. J Am Chem Soc 79: 4559-4560, 1957.
16. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA and Fryer JG: A prospective randomized comparison of continuous infusion of fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-Atlantic Oncology Program study. J Clin Oncol 17: 425-432, 1989. (Pubitemid 19098135)
17. Takenoue T, Kitayama J, Takei Y, Umetani N, Matsuda K, Nita ME, Hatano K, Tsuruo T and Nagawa H: Characterization of dihydropyrimidine dehydrogenase on immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression. Ann Oncol 11: 273-279, 2000. (Pubitemid 30214663)
18. Takenoue T, Nagawa H, Matsuda K, Fujii S, Nita ME, Kitayama J, Tsuruo T and Muto T: Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann Surg Oncol 7: 193-198, 2000. (Pubitemid 30215157)
19. Banerjee D, Schnieders B, Fu JZ, Adhikari D, Zhao S-C and Bertino JR: Role of E2F-1 in chemosensitivity. Cancer Res 58: 4292-4296, 1998. (Pubitemid 28450028)
20. Sargent DJ, Niedzwiecki D, O'Connell MJ and Schilsky RL: Recommendation for caution with irinotecan, fluorouracil, and lecovorin for colorectal cancer. N Engl J Med 345: 144-145, 2001.